Razieh Amini

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Combination Therapy

Cell Cycle Arrest

Signaling Pathway

Top Venues

Oxidative medicine and cellular longevity

Evidence-based complementary and alternative medicine : eCAM

Molecular biology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Razieh Amini, Shadi Moradi, Rezvan Najafi, Mehrdokht Mazdeh, Amir Taherkhani
BACE1 Inhibition Utilizing Organic Compounds Holds Promise as a Potential Treatment for Alzheimer's and Parkinson's Diseases. Oxidative medicine and cellular longevity 2024 (2024)
Razieh Amini, Shadi Moradi, Rezvan Najafi, Mehrdokht Mazdeh, Amir Taherkhani
BACE1 Inhibition Utilizing Organic Compounds Holds Promise as a Potential Treatment for Alzheimer's and Parkinson's Diseases. Oxidative medicine and cellular longevity 2024 (2024)
Razieh Amini, Shadi Moradi, Rezvan Najafi, Mehrdokht Mazdeh, Amir Taherkhani
BACE1 Inhibition Utilizing Organic Compounds Holds Promise as a Potential Treatment for Alzheimer's and Parkinson's Diseases. Oxidative medicine and cellular longevity 2024 (2024)
Mina Eslami, Farid Azizi Jalilian, Rezvan Najafi, Ali Mahdavinezhad, Razieh Amini
Promising Modulatory Effects of Cenicriviroc on the Progression of Mouse Colorectal Cancer through Inhibition of CCR2_CCL2 Signaling Pathway. Evidence-based complementary and alternative medicine : eCAM 2023 (2023)
Sima Nobari, Rezvan Najafi, Ali Mahdavinezhad, Akram Jalali, Razieh Amini
The Combination of Zerumbone with 5-Fluorouracil for Sensitizing Colorectal Cancer-Associated Fibroblasts to Treatment. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Razieh Dehghan, Rezvan Najafi, Farid Azizi Jalilian, Massoud Saidijam, Zahra Radaei, Alireza Zamani, Razieh Ezati, Farzaneh Asna-Ashari, Razieh Amini
A promising effect of zerumbone with improved anti-tumor-promoting inflammation activity of miR-34a in colorectal cancer cell lines. Molecular biology reports 48 (1) (2021)